Akoya Biosciences Inc investor relations material
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research. The company offers DyScribe In Situ Protein Synthesis Kit for in situ protein synthesis to enable scientists to study the proteome; and Akoya Preclinical, which is an in vivo visualization and signaling platform that enables scientists to visualize and precisely measure signal activation at the single cell level. It also provides Akoya XSpatial Platform for research, diagnostics, and bio-manufacturing applications. The company was founded in 2011 and is headquartered in Cambridge, Massachusetts.